Centiva Capital’s Bioventus BVS Stock Holding History

Centiva Capital’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-19,456	Closed	-$232K	–	1736
2024 Q3	$232K	Buy	+19,456	New	+$168K	﹤0.01%	1736

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Centiva Capital's BVS Position: Q4 2024 in Review

Centiva Capital sold out of Bioventus (BVS) in Q4 2024, closing a stake of 19,456 shares — an estimated $232K sold.

Centiva Capital first reported a position in BVS in Q3 2024 and held it in 1 quarter. The position peaked at $232K in Q3 2024. 151 funds tracked by Wall St. Rank hold BVS as of Q4 2024.

Centiva Capital reported no remaining Bioventus position as of Q4 2024 after selling out during the quarter.
Centiva Capital sold 19,456 Bioventus shares in Q4 2024, an estimated $232K.
Centiva Capital first reported a position in Bioventus in Q3 2024 and held it in 1 quarter.
Centiva Capital's Bioventus position peaked at $232K in Q3 2024.
151 funds tracked by Wall St. Rank held Bioventus as of Q4 2024.

Based on Centiva Capital's 13F filing for Q4 2024, filed 14 Feb 2025.